Children living with sickle cell can be treated safely using hydroxyurea, 10-year trial finds

Children living with sickle cell anemia have no higher incidence of clinically diagnosed infections when treated with hydroxyurea.

New research shows the efficacy and safety of hydroxyurea treatment for sickle cell anemia at four low-income sites in Africa, with no increase in clinically diagnosed infections.